ACMS #32, November 2020

The 32nd meeting of the Advisory Committee on Medicines Scheduling (ACMS #32), November 2020.

Date

3 May 2020

A meeting of the Advisory Committee on Medicines Scheduling (ACMS).

Members

The committee members are professionals with specific scientific, medical or clinical expertise, or expertise in consumer health issues relating to medicines.

Pre-meeting notice

For the pre-meeting public consultation notice go to:

Consultation: Proposed amendments to the Poisons Standard - ACMS, ACCS and Joint ACMS/ACCS meetings, November 2020.

Outcomes

Notice of final decisions to amend (or not amend) the current Poisons Standard in relation to Psilocybin and MDMA

15 December 2021

Scheduling decisions (final)

Final decisions on proposed amendments to the Poisons Standard relating to MDMA and psilocybin.
Notice of final decisions - ACMS #32, ACCS #29, Joint ACMS-ACCS #26, November 2020 meetings

19 July 2021

Scheduling decisions (final)

Notice of final decisions to amend the Poisons Standard - ACMS #32, Joint ACMS-ACCS #26, ACCS #29 (November 2020).
Public submissions on interim decisions for scheduling matters referred to the ACMS #32, ACCS #29 and Joint ACMS-ACCS #26 meetings held in November 2020

19 July 2021

Scheduling submissions

Public submissions made in response to the interim decisions published on 3 February 2021

Topics

Meeting of

Advisory Committee on Medicines Scheduling (ACMS)

Sub menu

ACMS #32, November 2020

Members

Pre-meeting notice

Outcomes

Notice of final decisions to amend (or not amend) the current Poisons Standard in relation to Psilocybin and MDMA

Notice of final decisions - ACMS #32, ACCS #29, Joint ACMS-ACCS #26, November 2020 meetings

Public submissions on interim decisions for scheduling matters referred to the ACMS #32, ACCS #29 and Joint ACMS-ACCS #26 meetings held in November 2020

Related content

GMP Forum 2024

Help us improve the Therapeutic Goods Administration site